The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.

This article highlights three leading Canadian cannabis stocks to watch in March. Aurora Cannabis Inc. (ACB), Village Farms International Inc. (VFF), and SNDL Inc. are key players in the sector. Each company has carved out its niche and demonstrated growth potential. Investors should consider recent financial results, expansion plans, and market positioning before making decisions.

[Read More] 3 Marijuana Stocks To Keep On Your Radar 2025

Top Canadian Cannabis Stocks for March 2025: Who’s Leading the Market?

1. Aurora Cannabis Inc. (NASDAQ: ACB)
2. Village Farms International Inc. (NASDAQ: VFF)
3. SNDL Inc. (NASDAQ: SNDL)

Aurora Cannabis Inc. (ACB)

Aurora Cannabis is a well-known Canadian cannabis producer with a focus on medical and recreational markets. The company has a global presence, supplying cannabis to more than 20 countries. Although its U.S. exposure is limited, Aurora has made strategic investments in the hemp-derived CBD market. The company operates multiple production facilities across Canada, ensuring large-scale supply capabilities. It does not currently own or operate dispensaries in the U.S., but it remains positioned for potential market expansion.

Aurora continues to focus on the medical cannabis industry, which provides steady revenue streams. It has also been expanding its premium cannabis offerings, targeting higher-margin products. The company’s research and development efforts aim to improve product quality and innovation. Aurora’s strong brand portfolio gives it a competitive edge in the Canadian market.

Financials

In its latest financial report, Aurora showed signs of stabilization. The company reported net revenue of C$63 million, reflecting steady medical cannabis sales. Gross margins improved due to cost-cutting initiatives and operational efficiencies. Aurora also reduced its debt significantly, strengthening its financial position. Despite challenges in the recreational market, its medical cannabis business remains a strong performer.

The company has been working on achieving profitability by controlling expenses. It continues to focus on reducing costs while increasing high-margin product offerings. Aurora’s long-term strategy includes potential U.S. market entry if federal legalization occurs. Investors should monitor its cash flow management and operational improvements.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Village Farms International Inc. (VFF)

Village Farms International is a Canadian agricultural company that has successfully transitioned into the cannabis industry. Originally a greenhouse vegetable grower, it has leveraged its expertise in controlled-environment farming to cultivate cannabis. Through its wholly owned subsidiary, Pure Sunfarms, the company has become one of Canada’s leading cannabis producers.

While Village Farms primarily operates in Canada, it has expanded its footprint in the U.S. through its hemp and CBD business. The company has partnerships and supply agreements in various states. Although it does not own dispensaries, its cannabis products are widely distributed through licensed retailers. Pure Sunfarms’ strong brand presence has helped it capture a significant Canadian market share.

The company’s ability to produce cannabis at a low cost gives it a competitive advantage. Its large-scale greenhouses allow for efficient cultivation, resulting in higher margins. This efficiency has helped Village Farms maintain a strong financial position in the industry.

Financials

Village Farms reported a net revenue of C$74.6 million in its latest earnings release. The company’s cannabis segment contributed C$36.7 million, reflecting steady growth in market demand. Pure Sunfarms remained a top-selling brand in Canada, driving strong sales performance. The company also improved its gross margin to 34%, showcasing cost efficiencies.

One of the biggest highlights was its positive adjusted EBITDA, indicating profitability in a challenging market. Village Farms continues to focus on expanding its cannabis portfolio while maintaining its core agricultural operations. The company remains optimistic about its U.S. expansion strategy, particularly in the CBD and hemp space.

Village Farms’ financial health is a key strength. It has maintained strong cash reserves, allowing flexibility for future investments. The company is positioned well for long-term success by focusing on cost control and innovation. Investors should watch for updates on potential U.S. legalization developments.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

SNDL Inc.

SNDL is one of Canada’s most diversified cannabis companies. It operates in both the retail and cultivation sectors, making it a unique player in the market. The company owns over 200 dispensaries across Canada under brands like Spiritleaf and Value Buds. This substantial retail presence provides SNDL with direct consumer access, helping it capture market share.

In addition to retail operations, SNDL is a major cannabis producer with large-scale cultivation facilities. The company focuses on premium and value-priced cannabis products, catering to a broad consumer base. It has expanded its portfolio through strategic acquisitions, including liquor retail businesses. This diversification reduces reliance on cannabis sales alone.

Although its U.S. presence is currently limited, SNDL has made investments that could facilitate future entry into the American market. The company remains focused on expanding its market share and enhancing product offerings.

Financials

SNDL’s latest financial report showed revenue of C$230.5 million, reflecting strong retail sales growth. The company’s cannabis segment contributed C$66.2 million, driven by increased product demand. It also reported a significant improvement in gross margins, benefiting from operational efficiencies.

One of the key highlights was SNDL’s positive adjusted EBITDA, marking a shift towards profitability. The company has been aggressively reducing costs and streamlining operations. Its diversified business model provides stability in an otherwise volatile industry.

SNDL also strengthened its balance sheet, reducing debt and increasing cash reserves. This financial discipline gives it flexibility for future expansion. The company continues to focus on optimizing its retail operations and product offerings. Investors should monitor the company’s progress in scaling operations while maintaining profitability.

Canada’s Top Cannabis Stocks for March 2025 Strong Picks for Investors

The Canadian cannabis sector remains a dynamic and evolving industry. Companies like Aurora Cannabis, Village Farms International, and SNDL continue to adapt to market conditions and position themselves for future growth. Each company has its unique strengths, from Aurora’s global medical cannabis presence to Village Farms’ low-cost production model and SNDL’s extensive retail network.

Financial performance is improving, with cost-cutting measures and operational efficiencies playing key roles. Investors should monitor revenue trends, profitability metrics, and expansion strategies. With potential U.S. legalization on the horizon, these companies could benefit from broader market opportunities.

As the cannabis industry continues to develop, selecting the right stocks requires careful analysis. Investors should consider financial stability, market positioning, and long-term growth potential. Watching how these companies navigate challenges will be crucial in assessing their future success.

The post Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis real estate sector continues to grow as demand for property financing increases. Cannabis REITs provide capital for dispensaries and cultivation facilities, helping operators expand while securing long-term rental income. The U.S. cannabis market is projected to reach $71 billion by 2030, driven by new state legalizations and rising consumer demand. Recent news suggests that federal rescheduling of cannabis could move forward in 2024, potentially easing banking restrictions. This change would benefit cannabis REITs by improving tenant stability. Investors should focus on companies with strong balance sheets and reliable rental income to reduce risk.

Using technical analysis can help identify optimal entry points for cannabis REITs. Watching support and resistance levels, trading volume, and moving averages can improve decision-making. Proper risk management is essential, as stock prices can be volatile. Setting stop-loss levels and position sizing carefully can help protect capital. As legalization expands, REITs will play a key role in industry growth, making them attractive for long-term investors.

The cannabis real estate sector is critical to the industry’s growth. Real Estate Investment Trusts (REITs) provide capital for cannabis operators through property acquisitions and lease agreements. As the market expands, these REITs help companies scale operations while securing long-term rental income. With uncertain federal legalization, these REITs offer investors indirect exposure to the cannabis industry.

This month, three cannabis REITs stand out due to their performance and recent developments. Innovative Industrial Properties, Inc. (IIPR), NewLake Capital Partners, Inc. (NLCP), and Chicago Atlantic Real Estate Finance, Inc. (REFI) are among the top REITs to watch. They own and manage properties leased to leading cannabis operators in the U.S. Their financials, dividends, and acquisitions make them attractive investment options. Below is a closer look at these companies.

[Read More] 3 Important Marijuana Stocks Giving Investors Hope

Best Cannabis REITs to Buy Now for Stability and Passive Income

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties (IIPR) is one of the largest cannabis-focused REITs in the U.S. The company specializes in acquiring and leasing industrial properties to state-licensed cannabis operators. It has a diverse portfolio covering multiple states, including California, Florida, and Pennsylvania. These regions have some of the most established cannabis markets.

As of early 2024, IIPR owns over 100 properties across 19 states. Its tenants include major multi-state operators (MSOs) such as Curaleaf, Trulieve, and Green Thumb Industries. The company follows a sale-leaseback model, allowing cannabis businesses to free up capital while securing long-term leases. This strategy has positioned IIPR as a key player in the sector.

In its latest earnings report, IIPR showed strong revenue growth. For the third quarter of 2023, revenue reached $79.9 million, reflecting a 12% increase year-over-year. The company also reported a net income of $40.8 million, maintaining profitability despite market challenges.

One of IIPR’s main attractions is its dividend payments. The company offers a high-yield dividend, making it appealing to income-focused investors. However, concerns about tenant defaults have impacted its stock price. Some cannabis operators have struggled with cash flow, affecting lease payments.

Despite these challenges, IIPR continues to expand its portfolio. The company remains a leader in cannabis real estate, with solid financials and a growing market presence. Investors watching this stock should consider its stability, dividend returns, and the evolving regulatory landscape.

[Read More] Here Are 2 Top Marijuana Stocks To Know About

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners (NLCP) is a smaller but growing cannabis REIT. It focuses on acquiring retail and industrial properties leased to state-licensed cannabis operators. The company has built a strong presence in Illinois, Massachusetts, and Pennsylvania, which are key cannabis markets in the U.S.

NLCP owns 32 properties across 12 states, supporting both medical and recreational cannabis businesses. Its tenants include top cannabis operators like Cresco Labs, Columbia Care, and Trulieve. The company follows a triple-net lease model, meaning tenants cover property expenses, reducing NLCP’s operational risks. This structure ensures steady rental income and long-term growth potential.

Although smaller than IIPR, NLCP has positioned itself as a reliable REIT with consistent revenue growth. Its strategic property acquisitions and long-term leases offer stability in the cannabis real estate market. As legalization expands, the demand for quality real estate will likely drive NLCP’s growth.

In its most recent financial report, NLCP generated $13.4 million in revenue, marking a 9% year-over-year increase. Net income reached $6.2 million, reflecting solid profitability. The company’s funds from operations (FFO), a key REIT performance metric, also showed improvement.

NLCP pays a quarterly dividend, offering investors consistent returns. Its last report declared a dividend of $0.39 per share, making it an attractive option for income investors. The company maintains a strong balance sheet with low debt, giving it flexibility for future acquisitions.

Looking ahead, NLCP is expected to expand its property portfolio as more states legalize cannabis. The company’s growth strategy and focus on high-quality tenants position it well for long-term success. Investors interested in cannabis real estate should watch NLCP’s developments.

[Read More] Top U.S. Marijuana Penny Stocks to Watch in Q1 2025 for High-Growth Potential

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance (REFI) is a unique player in the cannabis REIT sector. Unlike traditional REITs, REFI focuses on providing loans and credit facilities to cannabis operators. It helps businesses secure financing for expansion, property acquisitions, and operational needs.

REFI operates in some of the fastest-growing cannabis markets, including Michigan, Florida, and New Jersey. The company’s lending strategy allows it to work with both multi-state operators and independent cannabis businesses. By focusing on debt financing, REFI reduces exposure to property management risks while generating interest income.

The company has structured its investments to minimize default risks. Most of its loans are collateral-backed, ensuring that it can recover assets if borrowers face financial trouble. This approach has helped REFI maintain steady earnings while supporting cannabis industry growth.

In its latest earnings report, REFI posted $14.1 million in revenue, marking a 10% increase year-over-year. Net income came in at $7.2 million, reflecting strong profitability. The company’s loan portfolio continues to grow, with an emphasis on high-credit-quality borrowers.

REFI also offers a strong dividend yield, attracting income-focused investors. The company recently declared a dividend of $0.47 per share, reflecting its commitment to shareholder returns. As demand for cannabis financing increases, REFI is well-positioned to expand its lending activities.

Looking ahead, REFI plans to grow its loan portfolio and expand into new legal cannabis markets. The company’s focus on debt financing gives it a unique advantage in the sector. Investors seeking exposure to cannabis real estate with lower property management risks should consider REFI.

[Read More] 3 Marijuana Stocks That Could Soon Make Investors Big Profits

High-Yield Cannabis REITs to Watch in a Growing Market

The cannabis REIT sector remains a strong investment option despite market volatility. IIPR, NLCP, and REFI each offer unique opportunities for investors. IIPR stands out for its large portfolio and high dividend yield. NLCP is a smaller but growing REIT with a stable rental income. REFI provides financing solutions, reducing traditional REIT risks while maintaining strong earnings.

As cannabis legalization progresses, demand for real estate and financing will continue to grow. These REITs are critical in supporting cannabis businesses while offering investors potential long-term returns. Investors should monitor their financial performance and regulatory developments before making investment decisions.

The post 3 Must-Watch Cannabis REITs for Real Estate Investment in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks are in the same spot where the market is going to have issues with volatility. Due to the political landscape of passing federal reform or any cannabis laws, the next 4 years will be interesting. At this time most people inside Donald Trump’s cabinet are not in favor of legal cannabis.

Some of them are even working to reverse laws and make even more trouble for the legal market and its operators. Investor confidence in finding marijuana stocks to buy can be influenced by political circumstances. If investors perceive a hostile federal environment, they may be hesitant to invest, reducing capital flow into the sector.

Under the Trump administration, there is a lack of support for marijuana legalization at the federal level. This has led to uncertainty and has challenged the growth potential of cannabis companies. If similar sentiments continue in future administrations, it could hinder progress in federal reforms that would benefit the industry.

Still, there is much optimism as the demand and money being made from legal cannabis increases. Many companies are shown to be profitable as a business yet this success has not shown as much in the public sector. Still with hopes high for the future some marijuana stocks to watch could soon see moments of strong trading throughout 2025.

Top Marijuana Stocks For 2025

1. Jushi Holdings Inc. (OTC:JUSH)
2. SNDL Inc. (NASDAQ:SNDL)

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. In recent news, the company announced its support for the of Adult Use cannabis in Pennsylvania.

Words From The Company

“Jushi and its subsidiaries’ hundreds of employees here in the Commonwealth of Pennsylvania are pleased that the legalization of cannabis is once again a priority for the legislative session. And while we agree that there are important budget implications to this policy, it is also critically important to extend public protections of the regulated medical market we’ve created to the adult use marketplace.”

[Read More] Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth

SNDL Inc.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. Back in mid-January 2025 the company announced a partnership with HYTN Innovations Inc.

Under the agreement which was signed January 17, 2025, neither HYTN nor SNDL are obligated to exclusivity. While key milestones include the processing of three (3) commercial batches, there is no obligation regarding sales volume or pricing terms.

[Read More] Here Is How Marijuana Stocks Are Impact By The Cannabis Industry

Upon completion of the development phase, both parties may explore a commercial manufacturing agreement for vape cartridges.

The post These Marijuana Stocks Could Make The Difference In Your Portfolio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no federal reform that protects legal operators in any way. Yet states have independently voted to legalize cannabis. From this legal markets are created and legal companies can now produce a federally illegal product.

This is where the grey area of legal cannabis thrives. However, this has also added unwanted levels of downward trading levels for the public side of the industry. The amount of progress and money being made since 2020 has left many people stunned. With all this success and through the ups and downs cannabis is now becoming more accepted as a social norm. This is part of the bigger picture for marijuana as hopes are high for the future of the industry at large.

As the public still shows heavy drops in trading this could be your window to find top marijuana stocks to buy at low share prices. You always want to buy low and sell high and create a game plan that works with your style of investing and trading. Always do your research and be as patient as things can change without warning. Below are several marijuana stocks to watch that could soon see a bounce in trading.

Marijuana Stocks To Watch 2025

1. Aurora Cannabis Inc (NASDAQ:ACB)
2. Tilray Brands, Inc. (NASDAQ:TLRY)
3. Cronos Group Inc.(NASDAQ:CRON)

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally. In recent news, the company announced a supply agreement with SNDL.

Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower products grown at SNDL’s indoor facility. The term of the agreement is for three years with an option to extend and an estimated value of $27 million. Aurora and SNDL have an existing and successful supply relationship for the manufacturing of various cannabis products and input materials.

[Read More] Canadian Cannabis Market Update: Best Stocks to Track in February 2025

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

On February 5th the company announced it has partnered with Jet Blue. With this partnership, Jet Blue will serve The Surf Beer Golden Ale on its air crafts which is a product of Tilray.

Words From The Company

Vaughan Cutillo, Co-founder of Montauk Brewing, says, “We are proud and excited that JetBlue selected our Montauk Surf Beer Golden Ale to offer to travelers worldwide.”

[Read More] Ancillary Cannabis Stocks to Watch in February: Strong Picks for 2025

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany. Back in November 2024, the company reported its Q3 2024 earnings.

Third Quarter 2024

• Net revenue of $34.3 million in Q3 2024 increased by $9.5 million from Q3 2023.
• Gross profit of $3.6 million in Q3 2024 decreased by $0.4 million from Q3 2023.
• Adjusted Gross Profit of $10.7 million in Q3 2024 increased by $6.8 million from Q3 2023.
• Adjusted EBITDA of $(6.0) million in Q3 2024 improved by $9.2 million from Q3 2023. a

The post 3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to grow, offering significant opportunities for investors. In 2024, the legal cannabis market reached $34 billion in sales. Analysts expect it to surpass $50 billion by 2030 as more states legalize marijuana. Currently, 38 states allow medical cannabis, while 24 states permit recreational use. Recently, lawmakers introduced new federal legalization bills, sparking investor interest. However, marijuana stocks remain volatile, making penny stocks an attractive but risky option. These low-priced stocks can deliver high gains but require careful research. Traders should watch market trends, company fundamentals, and legalization updates.

Using technical analysis can help identify strong entry and exit points. Key indicators like moving averages, RSI, and volume trends provide insights into price movements. Risk management is essential, as penny stocks can be highly speculative. Setting stop-loss orders and position limits can help reduce potential losses. Investors should stay updated on industry news and regulatory changes for better decision-making.

The cannabis industry remains a volatile yet promising sector for investors. As federal legalization discussions continue, penny stocks present high-risk, high-reward opportunities. Many marijuana stocks trade at low prices due to market uncertainty. However, these companies continue expanding operations and generating revenue growth.

For February 2025, three marijuana penny stocks stand out: Cannabis Bioscience International Holdings, Inc. (CBSTF), Cansortium Inc. (CNTMF), and Cresco Labs Inc. (CRLBF). These companies operate in key U.S. markets and could benefit from potential policy shifts. Investors should closely monitor their financial performance, expansion strategies, and stock movements. Using technical analysis and proper risk management is crucial when trading penny stocks.

[Read More] Top Canadian Cannabis Stocks in 2025: What to Watch in January

Marijuana Penny Stocks to Watch in February 2025 as Industry Demand Grows

1. Cannabis Bioscience International Holdings, Inc. (OTC: CBSTF)
2. Cansortium Inc. (OTC: CNTMF)
3. Cresco Labs Inc. (OTC: CRLBF)

Cannabis Bioscience International Holdings, Inc.

Cannabis Bioscience International Holdings, Inc. (CBSTF) is a biotechnology-driven cannabis company. It focuses on research, product development, and medical cannabis applications. The company has a strong presence in California and Florida, where demand for cannabis-based treatments is high. CBSTF works closely with dispensaries, research institutions, and healthcare providers.

While it does not directly own dispensaries, it partners with several licensed operators. These partnerships help distribute its medical cannabis products across multiple states. The company specializes in cannabinoid-based formulations targeting pain management and neurological disorders. Its innovative approach to medical cannabis makes it a unique player in the industry. Investors should watch how CBSTF navigates regulatory challenges and expands its market reach.

CBSTF recently reported steady revenue growth, driven by increased demand for medical cannabis solutions. The company’s latest earnings showed a 10% rise in quarterly revenue compared to the previous year. This growth is largely due to expanded partnerships and new product launches.

Operating expenses remain a concern, as research and development costs are high. However, the company continues to secure funding through strategic partnerships and private investments. Its latest financial report also highlighted improved gross margins, which could support long-term sustainability.

If CBSTF maintains its growth trajectory, it could attract institutional investors. Regulatory changes favoring medical cannabis could further enhance its market position. Investors should keep an eye on profitability trends, licensing agreements, and new clinical trials.

[Read More] This Is What Could Happen To Marijuana Stocks In 2025

Cansortium Inc.

Cansortium Inc. (CNTMF) is a vertically integrated cannabis company based in Florida. It operates under the “Fluent” brand, serving medical cannabis patients across multiple states. The company has a strong presence in Florida, Texas, Pennsylvania, and Michigan. Florida remains its largest market, with over 30 dispensaries statewide.

Cansortium focuses on high-quality medical cannabis products, including flower, edibles, and vape cartridges. It continues expanding its footprint, particularly in Florida, where medical cannabis demand is growing. The company aims to capitalize on Florida’s potential shift toward recreational legalization. If legislation changes, CNTMF could see significant revenue growth.

CNTMF’s most recent earnings report showed solid revenue performance, with quarterly sales surpassing $20 million. Florida operations contributed the largest share, with same-store sales increasing. The company also reported an improvement in gross profit margins, reflecting better operational efficiency.

Despite revenue growth, CNTMF faces financial challenges. Debt remains a key issue, and management is actively working on restructuring strategies. The company is focusing on cost-cutting measures and optimizing supply chain operations. These efforts aim to improve long-term profitability and financial stability.

Investors should monitor debt-reduction plans, expansion efforts, and potential M&A activity. If Florida legalizes adult-use cannabis, CNTMF could experience a significant upside. However, cautious risk management is essential, given the stock’s volatility.

[Read More] 3 Marijuana Stocks And How The Sector Could Perform In 2025

Cresco Labs Inc.

Cresco Labs Inc. (CRLBF) is one of the largest multi-state cannabis operators in the U.S. The company has a strong retail and wholesale presence, making it a key industry player. Its largest markets include Illinois, Pennsylvania, and Ohio. Currently, Cresco operates over 60 dispensaries nationwide, with a focus on highly populated regions.

The company owns and operates the Sunnyside dispensary brand, which has gained consumer recognition. Cresco’s product portfolio includes flower, vapes, edibles, and concentrates, distributed across various retail locations. Its wholesale division supplies cannabis to over 1,000 dispensaries across multiple states.

CRLBF’s latest financials show strong revenue growth, exceeding $200 million in quarterly sales. However, profitability remains a challenge due to high tax burdens and operational costs. The company continues to focus on cost efficiency, aiming to improve EBITDA margins.

Recent financial reports indicate increased gross margins, driven by improved supply chain management. However, net losses persist due to high regulatory compliance costs. Cresco’s expansion into new adult-use markets, including Ohio and Pennsylvania, could drive future revenue growth.

Investors should track cash flow trends, cost-cutting initiatives, and state-level legalization efforts. If Cresco maintains strong revenue momentum, it could be a leading player in the evolving cannabis market. However, market volatility and federal policy changes remain key risks.

[Read More] 2 Top Tier Cannabis Stocks For Better Investing 2025

Undervalued Cannabis Penny Stocks to Watch in February for Potential Upside

Marijuana penny stocks present exciting opportunities, but they come with significant risks. CBSTF, CNTMF, and CRLBF each offer unique strengths and potential for growth. Cannabis Bioscience (CBSTF) specializes in biotech-driven cannabis solutions, while Cansortium (CNTMF) dominates the Florida medical market. Cresco Labs (CRLBF) remains a major multi-state operator with strong wholesale revenue.

Investors should conduct thorough research before investing in cannabis stocks. Monitoring financial performance, expansion plans, and industry trends is essential. As federal legalization discussions continue, these stocks could see increased investor interest. However, proper risk management is necessary due to industry volatility.

By staying informed and using technical analysis, investors can navigate the cannabis penny stock sector more effectively. Keep an eye on these companies as they position themselves for potential future growth.

The post February’s Top Marijuana Penny Stocks: High-Growth Potential in a Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

As the entirety of the cannabis industry further evolves, 2025 aims to be a key year for marijuana stocks. Stronger efforts on legalization across various states and countries. As well as the change in public perception of the plant. Which has gradually transformed the cannabis sector into a burgeoning market. Investors are starting to acknowledge the potential of marijuana stocks with all the current industry success. Much of this is fueled by the prospects of mainstream acceptance and integration into the global economy.

Over the last decade, there have been significant breakthroughs in legislation, particularly in the United States. From this, it is expected to drive enhanced market dynamics. With the last few states working toward legalizing cannabis in some form, companies in the cannabis sector may once again gain the stability and growth they have been eagerly anticipating. Analysts forecast that better laws and regulations will encourage both new and seasoned investors to participate in the market, searching for top marijuana stocks to buy in 2025.

Furthermore, improvements in cultivation, product creation, and strategic partnerships will likely create a competitive edge for leading companies. This competition will help generate more revenue while meeting consumer demand for more cannabis, further attracting investor interest. As the narrative surrounding cannabis shifts from stigma to opportunity, 2025 could mark a turning point, with marijuana stocks poised for a resurgence that could captivate the investment community. Below are some marijuana stocks to watch in 2025 for better trading momentum.

Marijuana Stocks For Investors

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. Green Thumb Industries Inc. (OTC:GTBIF)
3. Curaleaf Holdings, Inc. (OTC:CURLF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.

On January 16th the company announced the opening of a new dispensary in Zanesville, Ohio.

Words From The Company

“We are excited to bring Trulieve’s affordable, high-quality products and elevated customer experience to Muskingum County,” said Trulieve’s Chief Executive Officer Kim Rivers. “We look forward to building relationships with customers in the Zanesville area.”

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments: Retail and Consumer Packaged Goods.

In recent news, the company announced it will host a Q4 and full 2024 earnings conference call. The company has set February 26th, 2025, as the date on which the conference will take place.

[Read More] Could These 3 Marijuana Stocks To Buy Be Worth It?

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations.

At the start of January 2025, the company celebrated Dry January with the debut of its 2.5. mg Zero Proof Hemp Seltzers new flavors.

[Read More] Top Cannabis REITs Driving Industry Expansion in 2025

Words From The CEO

“We are proud to be a trusted and reliable industry leader in the quickly evolving market for hemp-derived products,” said Boris Jordan, Chairman & CEO of Curaleaf. “The new 2.5 mg Select Zero Proof Seltzer, and new flavors, exemplify how we respond directly to consumer feedback to deliver an excellent product.”

The post 3 Big Name Marijuana Stocks In The Cannabis Sector appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry remains a focal point for investors, especially with recent federal developments. Last week, a bill proposing federal cannabis legalization was reintroduced in Congress, reigniting optimism for the sector’s future. If passed, this legislation could address federal banking restrictions and support cannabis businesses. The US cannabis market is projected to reach $41.5 billion by 2025, according to industry reports. With 39 states already permitting medical or recreational cannabis, the potential for federal reform could accelerate growth. This week, these developments make cannabis-focused real estate investment trusts (REITs) particularly intriguing. REITs offer exposure to this rapidly growing sector while providing consistent dividend income.

Technical analysis and risk management are essential to navigate cannabis REITs. Monitoring support and resistance levels can guide entry and exit points. Additionally, REIT investors should consider dividend yields, occupancy rates, and tenant stability. Diversifying across REITs also minimizes risks. With proper research and strategies, investors can capitalize on this burgeoning industry while managing volatility.

The cannabis industry continues to experience significant growth, and cannabis-focused real estate investment trusts (REITs) have become key players in this expansion. These REITs provide essential financial and infrastructure support to cannabis operators by purchasing properties and leasing them back to businesses. In January 2025, three cannabis REITs stand out as promising investment opportunities: Innovative Industrial Properties, Inc. (IIPR), NewLake Capital Partners, Inc. (NLCP), and Chicago Atlantic Real Estate Finance, Inc. (REFI). Below, we explore each company’s operations and recent financial performance.

[Read More] 2 Marijuana Stocks To Follow In The Cannabis Sector

Top 3 Cannabis REITs to Watch in January 2025

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties (IIPR) is one of the most prominent cannabis-focused REITs in the United States. The company specializes in acquiring and leasing industrial and retail properties to licensed cannabis operators. As of January 2025, IIPR owns over 110 properties across 19 states, including key markets like California, Illinois, and Florida. Its largest presence is in California, where it supports cultivators and distributors. The company’s strategic focus on high-demand cannabis markets ensures strong tenant demand and steady income.

In its most recent financial results for Q4 2024, IIPR reported robust revenue growth. Rental revenues rose by 12% yearly, reaching $74 million for the quarter. Net income attributable to common shareholders was $35 million, or $1.22 per diluted share. Despite challenges from tenant issues in previous years, IIPR has improved its portfolio quality. The company maintains a strong balance sheet with over $1 billion in total assets and a debt-to-equity ratio below 0.5. Its dividend yield remains among the highest in the REIT sector, providing investors with a steady income.

[Read More] 2 Marijuana Stocks For Your Watchlist This Week

NewLake Capital Partners, Inc.

NewLake Capital Partners (NLCP) is another major cannabis REIT with a growing portfolio of properties. The company focuses on acquiring cultivation, processing, and retail facilities for state-licensed cannabis operators. As of January 2025, NLCP owns 32 properties across 15 states, with significant exposure in Colorado and Pennsylvania. Pennsylvania serves as its largest market, hosting multiple tenants in the medical cannabis space. NLCP’s strategy emphasizes partnering with top-tier cannabis operators to ensure stable lease agreements.

NLCP’s financial performance in 2024 reflects its steady growth trajectory. The company posted total revenue of $19 million in Q4 2024, up 10% from the previous quarter. Net income came in at $11 million, translating to $0.45 per share earnings. Management highlighted a 96% occupancy rate across its portfolio, showcasing strong tenant relationships. Furthermore, NLCP has maintained conservative financial practices, with a leverage ratio of 25%. The company increased its quarterly dividend by 5%, offering an attractive yield for investors seeking consistent returns.

[Read More] Top Canadian Cannabis Companies Poised for Market Growth in 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance (REFI) is a niche player among cannabis REITs, focusing on debt financing for cannabis operators. Instead of owning physical properties, REFI provides loans to operators for real estate development and working capital needs. As of January 2025, REFI has deployed over $500 million in loans to cannabis businesses across the United States. Its portfolio includes loans to operators in key states like Massachusetts, Nevada, and Michigan. This unique approach differentiates REFI from traditional cannabis REITs.

In its Q4 2024 financial results, REFI reported impressive earnings growth. Total revenue increased by 15% year-over-year, reaching $22 million. Net income for the quarter was $13 million, or $0.68 per share. The company’s loan portfolio maintained a weighted average yield of 12%, highlighting its ability to generate high returns. Despite the risks associated with cannabis lending, REFI has implemented stringent underwriting standards. This ensures credit quality while minimizing potential defaults. Its dividend payout ratio remains healthy, providing a yield of approximately 9%.

Maximize Returns with These Leading Cannabis REITs

These top three cannabis REITs—Innovative Industrial Properties (IIPR), NewLake Capital Partners (NLCP), and Chicago Atlantic Real Estate Finance (REFI)—clearly represent diverse opportunities in the cannabis sector. Specifically, IIPR leads with its extensive property portfolio; meanwhile, NLCP emphasizes partnerships with top operators. Furthermore, REFI carves a unique path with its focus on debt financing. Notably, each REIT has consistently demonstrated resilience and growth despite significant industry challenges. Therefore, they are worth closely watching in January 2025. For investors seeking exposure to cannabis with reliable income potential, these REITs undoubtedly offer compelling and attractive options.

The post Top Cannabis REITs Driving Industry Expansion in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to show remarkable growth, with sales projected to reach $41 billion by 2025. This expansion is driven by increasing legalization efforts and rising consumer demand. Notably, over 20 states have legalized recreational cannabis, while more than 30 allow medical use. In recent news, lawmakers are pushing for federal cannabis reform, which could significantly impact the market. Additionally, investor interest in marijuana penny stocks remains high, as these low-cost stocks offer substantial growth potential. Despite their volatility, penny stocks attract traders looking to capitalize on emerging trends in the cannabis sector.

When trading marijuana penny stocks, technical analysis and proper risk management are essential. Traders can identify optimal entry points by analyzing chart patterns and key support and resistance levels. Moreover, using tools like stop-loss orders can help mitigate losses in volatile markets. As legalization expands and the industry matures, these strategies can maximize opportunities while managing risks.

The cannabis industry in the United States has been gaining momentum, with growing legalization and increasing consumer demand. For January 2025, certain marijuana penny stocks are showing strong potential due to their market positioning and innovative strategies. Among them, AYR Wellness Inc. (AYRWF), Cansortium Inc. (CNTMF), and Glass House Brands Inc. (GLASF) stand out. These companies operate in the competitive cannabis space, offering investors an opportunity to explore growth at lower price levels.

[Read More] 3 Marijuana Stocks For Your 2025 Trading List

Top Marijuana Penny Stocks for January 2025

1. AYR Wellness Inc. (OTC: AYRWF)
2. Cansortium Inc. (OTC: CNTMF)
3. Glass House Brands Inc. (OTC: GLASF)

AYR Wellness Inc. (AYRWF)

AYR Wellness is a prominent multi-state operator (MSO) in the cannabis industry. The company operates across several states, including Florida, Pennsylvania, and New Jersey. Florida represents its largest presence, where it owns and operates over 50 dispensaries. AYR Wellness has positioned itself as a leader in high-quality cannabis products, focusing on a wide range of flower, vape, and edible options. Additionally, it emphasizes consumer education and accessibility, further strengthening its foothold in the industry. With legalization expanding, AYR continues to attract attention from investors looking for growth in established and emerging markets.

In its most recent earnings report, AYR Wellness showcased significant revenue growth, driven by its expansion in key states. Quarterly revenues reached $135 million, reflecting a 15% year-over-year increase. However, the company reported a net loss of $5 million, attributed to ongoing operational investments. On the brighter side, adjusted EBITDA was positive, standing at $20 million, indicating improvements in operational efficiency. Additionally, AYR’s management has expressed optimism about 2025, citing Florida’s strong sales and potential new market entries. The company also reduced debt by 8%, enhancing its financial stability. These financial moves signal a commitment to long-term growth and profitability.

[Read More] How Federal Legalization Could Boost Ancillary Cannabis Stocks in 2025

Cansortium Inc. (CNTMF)

Cansortium Inc., also known as Fluent Cannabis Care, is a vertically integrated cannabis company. The company is well-known for its operations in Florida, where it manages over 30 dispensaries. Florida is a crucial market for Cansortium, contributing significantly to its revenue stream. Additionally, Cansortium has operations in Texas, Michigan, and Pennsylvania, making it a regional leader in medicinal cannabis. The company focuses on cultivating premium-quality cannabis products, offering a diverse product line that includes flower, oils, and capsules. With a growing patient base and strategic expansions, Cansortium is poised for continued success.

Cansortium’s recent financial results highlight its steady growth, particularly in Florida. The company reported quarterly revenues of $26 million, marking a 12% increase from the prior year. Gross margins remained strong at 60%, showcasing effective cost management in cultivation and production. Despite these achievements, the company reported a modest net loss of $2 million due to higher administrative expenses. On a positive note, cash flow improved by 10%, supported by increased sales and efficient inventory management. Management has indicated plans to expand dispensaries in Florida while targeting new medicinal markets. These initiatives are expected to drive further growth in 2025.

[Read More] Cannabis Stocks to Watch in 2025: Top Companies and Trading Strategies to Consider

Glass House Brands Inc. (GLASF)

Glass House Brands is a leading California-based cannabis company specializing in large-scale cultivation and retail. The company operates several premium dispensaries across California, its largest market, and manages one of the country’s largest greenhouse cultivation facilities. With an annual production capacity of over 500,000 pounds of cannabis, Glass House emphasizes sustainability and efficiency in its operations. The company’s retail network consists of over 10 dispensaries, including locations in prominent regions like Los Angeles and Santa Barbara. By focusing on high-quality products and customer experience, Glass House Brands continues to capture market share in California’s competitive cannabis market.

In its recent earnings release, Glass House Brands reported strong revenue growth of 20% year-over-year, reaching $35 million. The company attributed this growth to increased cultivation output and higher dispensary sales. Gross margins improved to 50%, reflecting enhanced operational efficiency at its greenhouse facilities. Despite these gains, the company posted a net loss of $4 million, driven by higher marketing and distribution expenses. Glass House is also focused on reducing debt, recently restructuring $15 million in loans to strengthen its financial position. Looking ahead, management is optimistic about capturing more market share as California’s cannabis industry stabilizes.

Best Marijuana Penny Stocks for Short-Term Gains and Long-Term Growth

The cannabis industry is rapidly evolving, offering opportunities for growth and investment. AYR Wellness, Cansortium, and Glass House Brands are positioned to thrive in 2025 due to their market presence, operational strategies, and financial progress. However, it is essential for investors to consider the risks associated with penny stocks, including volatility and regulatory uncertainties. Investors can better navigate this promising sector by using technical analysis and proper risk management. As legalization expands, these companies could see significant upside in the coming years, making them stocks to watch closely this January.

The post Marijuana Penny Stocks to Add to Your Watchlist Today appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..